| Review Article Online Published: 18 Jan 2026 | ||||||||||||
IJMDC. 2026; 10(1): 495-506 Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized controlled trials Abdulrahman M. Azab, Hadeel F. Alazwari, Lama Mohammed Alqarni, Emtenan Sulaiman Yamani, Ghaythah Hamed Alkhathami, Raghad Hussain Alkhalifah, Shaimaa Hamza Banaji, Nouf Ahmad Aldhubabian, Sarah Mersal Almehmadi.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Azab AM, Alazwari HF, Alqarni LM, Yamani ES, Alkhathami GH, Alkhalifah RH, Banaji SH, Aldhubabian NA, Almehmadi SM. Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized controlled trials. IJMDC. 2026; 10(1): 495-506. doi:10.24911/IJMDC.51-1766048131 Web Style Azab AM, Alazwari HF, Alqarni LM, Yamani ES, Alkhathami GH, Alkhalifah RH, Banaji SH, Aldhubabian NA, Almehmadi SM. Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized controlled trials. https://www.ijmdc.com/?mno=303673 [Access: January 25, 2026]. doi:10.24911/IJMDC.51-1766048131 AMA (American Medical Association) Style Azab AM, Alazwari HF, Alqarni LM, Yamani ES, Alkhathami GH, Alkhalifah RH, Banaji SH, Aldhubabian NA, Almehmadi SM. Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized
controlled trials. IJMDC. 2026; 10(1): 495-506. doi:10.24911/IJMDC.51-1766048131 Vancouver/ICMJE Style Azab AM, Alazwari HF, Alqarni LM, Yamani ES, Alkhathami GH, Alkhalifah RH, Banaji SH, Aldhubabian NA, Almehmadi SM. Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized
controlled trials. IJMDC. (2026), [cited January 25, 2026]; 10(1): 495-506. doi:10.24911/IJMDC.51-1766048131 Harvard Style Azab, A. M., Alazwari, . H. F., Alqarni, . L. M., Yamani, . E. S., Alkhathami, . G. H., Alkhalifah, . R. H., Banaji, . S. H., Aldhubabian, . N. A. & Almehmadi, . S. M. (2026) Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized
controlled trials. IJMDC, 10 (1), 495-506. doi:10.24911/IJMDC.51-1766048131 Turabian Style Azab, Abdulrahman M., Hadeel F. Alazwari, Lama Mohammed Alqarni, Emtenan Sulaiman Yamani, Ghaythah Hamed Alkhathami, Raghad Hussain Alkhalifah, Shaimaa Hamza Banaji, Nouf Ahmad Aldhubabian, and Sarah Mersal Almehmadi. 2026. Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized
controlled trials. International Journal of Medicine in Developing Countries, 10 (1), 495-506. doi:10.24911/IJMDC.51-1766048131 Chicago Style Azab, Abdulrahman M., Hadeel F. Alazwari, Lama Mohammed Alqarni, Emtenan Sulaiman Yamani, Ghaythah Hamed Alkhathami, Raghad Hussain Alkhalifah, Shaimaa Hamza Banaji, Nouf Ahmad Aldhubabian, and Sarah Mersal Almehmadi. "Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized
controlled trials." International Journal of Medicine in Developing Countries 10 (2026), 495-506. doi:10.24911/IJMDC.51-1766048131 MLA (The Modern Language Association) Style Azab, Abdulrahman M., Hadeel F. Alazwari, Lama Mohammed Alqarni, Emtenan Sulaiman Yamani, Ghaythah Hamed Alkhathami, Raghad Hussain Alkhalifah, Shaimaa Hamza Banaji, Nouf Ahmad Aldhubabian, and Sarah Mersal Almehmadi. "Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized
controlled trials." International Journal of Medicine in Developing Countries 10.1 (2026), 495-506. Print. doi:10.24911/IJMDC.51-1766048131 APA (American Psychological Association) Style Azab, A. M., Alazwari, . H. F., Alqarni, . L. M., Yamani, . E. S., Alkhathami, . G. H., Alkhalifah, . R. H., Banaji, . S. H., Aldhubabian, . N. A. & Almehmadi, . S. M. (2026) Semaglutide 2.4 mg for weight loss in overweight adolescents and adults without diabetes: an updated systematic review and meta-analysis of randomized
controlled trials. International Journal of Medicine in Developing Countries, 10 (1), 495-506. doi:10.24911/IJMDC.51-1766048131 |